Natural Alternatives International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$NAII
Medicinal Chemicals and Botanical Products
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
DATE OF REPORT (Date of earliest event reported): December 5, 2025
(Commission file number)
(Exact name of registrant as specified in its charter)
|
|
|
|
(State of incorporation)
|
(IRS Employer Identification No.)
|
|
|
(
|
|
(Address of principal executive offices)
|
(Registrant’s telephone number)
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
ITEM 5.07
|
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
|
Our Annual Meeting of Stockholders was held on December 5, 2025. The following table sets forth the matters voted upon at the meeting and the results of the voting on each matter voted upon:
|
Matter Voted Upon
|
Votes For
|
Withheld
|
Votes
Against |
Abstentions
|
Broker
Non-Votes |
|||||||||||||||
|
Election of one Class II director to serve until the next annual meeting of stockholders held to elect Class II directors and until such director’s successor is elected and qualified:
|
||||||||||||||||||||
|
Alan G Dunn
|
3,096,094 | 132,700 | — | — | 1,519,356 | |||||||||||||||
|
Approval of the First Amendment to the 2020 Omnibus Equity Incentive Plan
|
3,025,686 | — | 195,970 | 7,138 | 1,519,356 | |||||||||||||||
|
Ratification of the selection of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026
|
4,660,314 | — | 83,683 | 4,153 | — | |||||||||||||||
|
To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers
|
3,092,272 | — | 99,248 | 37,274 | 1,519,356 | |||||||||||||||
|
An advisory, non-binding vote regarding the frequency of voting by the stockholders on the executive compensation of the Company's executive officers
|
||||||||||||||||||||
|
One year
|
1,165,476 | — | — | — | — | |||||||||||||||
|
Two years
|
20,602 | — | — | — | — | |||||||||||||||
|
Three years
|
2,006,157 | — | — | — | — | |||||||||||||||
| Abstentions and non-votes | — | — | — | 36,199 | 1,519,356 | |||||||||||||||
The election of the one named director, the First Amendment to the 2020 Omnibus Equity Incentive Plan, the Ratification of Haskell & White, the compensation of the named executive officers, and the three-year frequency of non-binding votes on executive compensation were each approved by the stockholders at the annual meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Natural Alternatives International, Inc.
|
||
|
Date: December 11, 2025
|
By:
|
/s/ Michael E. Fortin
|
|
Michael E. Fortin
|
||
|
Chief Financial Officer
|
||